-
The next patient in your examination room is an 18-year-old female who is seeking effective contraception. She has tried oral contraceptives (OCs), but she hasn't been successful in sticking with the dosing regimen. What options can you offer her?
-
When counseling a woman on when to start her first pack of oral contraceptives (OCs), what is your strategy for pill initiation? Most participants in the 2007 Contraceptive Technology Update Contraception Survey say they are using the Quick Start method.
-
A year ago, the introduction of the human papillomavirus (HPV) vaccine was being hailed as a major public health success story.
-
Outcomes for treatment of stroke with intravenous tissue plasminogen activator (tPA) were similar at community hospitals supported by telemedicine consultation with stroke experts compared to academic stroke centers.
-
Long-term monitoring is likely to detect atrial fibrillation in stroke patients with frequent atrial premature beats.
-
The US FDA Adverse Event Reporting System (AERS) was searched for reports of nephrolithiasis in HIV patients receiving atazanavir (ATV)-containing antiretroviral (ARV) regimens; 30 cases were identified.
-
Withdrawal of statin therapy in acute ischemic stroke may lead to increases in death and disability.
-
Carcinoma of unknown primary remains a management problem without an established approach demonstrated to prolong survival. In a phase II study, the combination of carboplatin, gemcitabine, and capecitabine was shown to be fairly well tolerated and, for certain subsets, effective in producing transient tumor regression.
-
When used in conjunction with clinical and radiographic data, brain natriuretic peptide levels may provide a non-invasive alternative for distinguishing between ARDS and cardiogenic pulmonary edema in patients with severe hypoxemic respiratory failure.
-
Although ECG is the standard initial screening test for acute coronary syndromes, its value for the diagnosis of acute myocardial infarction (MI) is difficult to determine because of the vagaries of serum biomarkers.
